(Q38211809)

English

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

scientific article published on 14 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

0 references

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis (English)

1 reference

Europe PubMed Central

31 August 2017

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Parkinson's disease dementia

1 reference

based on heuristic

inferred from title

dementia with Lewy bodies

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

object named as

Jin-Tai Yu

2

0 references

9

object named as

Lan Tan

1 reference

Europe PubMed Central

31 August 2017

4

object named as

Teng Jiang

1 reference

Europe PubMed Central

31 August 2017

6

object named as

Xiang-Fei Meng

1 reference

Europe PubMed Central

31 August 2017

author name string

Hui-Fu Wang

1

1 reference

Europe PubMed Central

31 August 2017

Shao-Wen Tang

3

1 reference

Europe PubMed Central

31 August 2017

Chen-Chen Tan

5

1 reference

Europe PubMed Central

31 August 2017

Chong Wang

7

1 reference

Europe PubMed Central

31 August 2017

Meng-Shan Tan

8

1 reference

Europe PubMed Central

31 August 2017

language of work or name

0 references

publication date

14 May 2014

1 reference

Europe PubMed Central

31 August 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

31 August 2017

86

1 reference

Europe PubMed Central

31 August 2017

2

1 reference

Europe PubMed Central

31 August 2017

135-143

1 reference

Europe PubMed Central

31 August 2017

Risk of dementia in Parkinson's disease: a community-based, prospective study.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

A systematic review of prevalence studies of dementia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Clinical diagnostic criteria for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Visual perception in Parkinson disease dementia and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Cholinergic dysfunction in diseases with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Treatment of dementia with Lewy bodies and Parkinson's disease dementia

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

A re-evaluation of random-effects meta-analysis.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem).

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2014-307659

21 January 2018

Identifiers

10.1136/JNNP-2014-307659

1 reference

Europe PubMed Central

31 August 2017

1 reference

Europe PubMed Central

31 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38211809&oldid=2117693092"